B. Riley Securities maintains Buy rating on OptimizeRx, $11 price target

B. Riley Securities maintained their Buy rating on OptimizeRx's stock with a price target of $11.00.The price target implies an upside of 40.8% from the Sep 28 close of $7.81.Key takeaways from the analyst noteStrong Margin Expansion: OptimizeRx has demonstrated significant improvements in its marg…